Cargando…
BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates
The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.) An analysis of 480 BALF samples was performed in patients with hematological malignancies ove...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090732/ https://www.ncbi.nlm.nih.gov/pubmed/31073843 http://dx.doi.org/10.1007/s12223-019-00712-4 |
_version_ | 1783509951841304576 |
---|---|
author | Zak, P. Vejrazkova, E. Zavrelova, A. Pliskova, L. Ryskova, L. Hubacek, P. Stepanova, V. Kostal, M. Koblizek, V. Paterova, P. Radocha, Jakub |
author_facet | Zak, P. Vejrazkova, E. Zavrelova, A. Pliskova, L. Ryskova, L. Hubacek, P. Stepanova, V. Kostal, M. Koblizek, V. Paterova, P. Radocha, Jakub |
author_sort | Zak, P. |
collection | PubMed |
description | The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.) An analysis of 480 BALF samples was performed in patients with hematological malignancies over a period of 7 years. The results of culture methods, PCR, and immunoenzymatic sandwich microplate assays for Aspergillus galactomannan (GM) in BALF were analyzed. Further, the diagnostic thresholds for Aspergillus GM and Pneumocystis jiroveci were also calculated. Microbiological findings were present in 87% of BALF samples. Possible infectious pathogens were detected in 55% of cases; 32% were classified as colonizing. No significant difference in diagnostic yield or pathogen spectrum was found between non-neutropenic and neutropenic patients. There was one significant difference in BALF findings among intensive care units (ICU) versus non-ICU patients for Aspergillus spp. (22% versus 9%, p = 0.03). The most common pathogens were Aspergillus spp. (n = 86, 33% of BAL with causative pathogens) and Streptococcus pneumoniae (n = 46, 18%); polymicrobial etiology was documented in 20% of cases. A quantitative PCR value of > 1860 cp/mL for Pneumocystis jirovecii was set as a diagnostic threshold for pneumocystis pneumonia. The absorbance index of GM in BALF of 0.5 was set as a diagnostic threshold for aspergillosis. The examination of BAL fluid revealed the presence of pathogen in more than 50% of cases and is, therefore, highly useful in this regard when concerning pulmonary infiltrates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12223-019-00712-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7090732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-70907322020-03-24 BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates Zak, P. Vejrazkova, E. Zavrelova, A. Pliskova, L. Ryskova, L. Hubacek, P. Stepanova, V. Kostal, M. Koblizek, V. Paterova, P. Radocha, Jakub Folia Microbiol (Praha) Original Article The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.) An analysis of 480 BALF samples was performed in patients with hematological malignancies over a period of 7 years. The results of culture methods, PCR, and immunoenzymatic sandwich microplate assays for Aspergillus galactomannan (GM) in BALF were analyzed. Further, the diagnostic thresholds for Aspergillus GM and Pneumocystis jiroveci were also calculated. Microbiological findings were present in 87% of BALF samples. Possible infectious pathogens were detected in 55% of cases; 32% were classified as colonizing. No significant difference in diagnostic yield or pathogen spectrum was found between non-neutropenic and neutropenic patients. There was one significant difference in BALF findings among intensive care units (ICU) versus non-ICU patients for Aspergillus spp. (22% versus 9%, p = 0.03). The most common pathogens were Aspergillus spp. (n = 86, 33% of BAL with causative pathogens) and Streptococcus pneumoniae (n = 46, 18%); polymicrobial etiology was documented in 20% of cases. A quantitative PCR value of > 1860 cp/mL for Pneumocystis jirovecii was set as a diagnostic threshold for pneumocystis pneumonia. The absorbance index of GM in BALF of 0.5 was set as a diagnostic threshold for aspergillosis. The examination of BAL fluid revealed the presence of pathogen in more than 50% of cases and is, therefore, highly useful in this regard when concerning pulmonary infiltrates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12223-019-00712-4) contains supplementary material, which is available to authorized users. Springer Netherlands 2019-05-09 2020 /pmc/articles/PMC7090732/ /pubmed/31073843 http://dx.doi.org/10.1007/s12223-019-00712-4 Text en © Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i. 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Zak, P. Vejrazkova, E. Zavrelova, A. Pliskova, L. Ryskova, L. Hubacek, P. Stepanova, V. Kostal, M. Koblizek, V. Paterova, P. Radocha, Jakub BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates |
title | BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates |
title_full | BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates |
title_fullStr | BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates |
title_full_unstemmed | BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates |
title_short | BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates |
title_sort | bal fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090732/ https://www.ncbi.nlm.nih.gov/pubmed/31073843 http://dx.doi.org/10.1007/s12223-019-00712-4 |
work_keys_str_mv | AT zakp balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates AT vejrazkovae balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates AT zavrelovaa balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates AT pliskoval balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates AT ryskoval balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates AT hubacekp balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates AT stepanovav balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates AT kostalm balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates AT koblizekv balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates AT paterovap balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates AT radochajakub balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates |